GL1X · GenesisL1 explorer

Research workbench

Crystal structure of ABL2/ARG kinase in complex with dasatinib

Analyse Crystal structure of ABL2/ARG kinase in complex with dasatinib in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4XLI
Type
protein
Length
528 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Non-specific protein-tyrosine kinase
EC
2.7.10.2
UniProt
F8VQH0
Ligands
1N1, ZN
Pockets
7 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 42% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ANon-specific protein-tyrosine kinase (EC 2.7.10.2)protein26442% helix, 19% strandF8VQH0
BNon-specific protein-tyrosine kinase (EC 2.7.10.2)protein26442% helix, 18% strandF8VQH0

Ligands and binding sites

  • 1N1 · N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl}amino)-1,3-thiazole-5-carboxamide · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

7 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14510.690.80391N1
22170.600.81251N1
3800.520.8419empty
4980.520.8222empty
51910.450.7425empty

Interfaces

1 interface between chains.

  • A–B · 774 Ų buried · 14 hydrogen bonds · protein-protein

Compared structures

  • 4XLI · Crystal structure of Abl2/Arg kinase in complex with dasatinib · the same entry in another collection · chain B against B, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.